These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8375123)

  • 41. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
    Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
    Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review of factors affecting the ratios of morphine and its major metabolites.
    Faura CC; Collins SL; Moore AR; McQuay HJ
    Pain; 1998 Jan; 74(1):43-53. PubMed ID: 9514559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers.
    Duflot T; Pereira T; Tavolacci MP; Joannidès R; Aubrun F; Lamoureux F; Lvovschi VE
    CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):82-93. PubMed ID: 34842366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.
    Osborne R; Joel S; Trew D; Slevin M
    Clin Pharmacol Ther; 1990 Jan; 47(1):12-9. PubMed ID: 2295214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.
    Samuelsson H; Hedner T; Venn R; Michalkiewicz A
    Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
    Faura CC; Moore RA; Horga JF; Hand CW; McQuay HJ
    J Pain Symptom Manage; 1996 Feb; 11(2):95-102. PubMed ID: 8907140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
    Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses.
    Hamamoto-Hardman BD; Steffey EP; Weiner D; McKemie DS; Kass P; Knych HK
    J Vet Pharmacol Ther; 2019 Jul; 42(4):401-410. PubMed ID: 30919469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses.
    Knych HK; Kanarr K; Fang Y; McKemie DS; Kass PH
    Vet Anaesth Analg; 2022 Nov; 49(6):634-644. PubMed ID: 35999165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal administration of morphine to healthy subjects.
    Westerling D; Höglund P; Lundin S; Svedman P
    Br J Clin Pharmacol; 1994 Jun; 37(6):571-6. PubMed ID: 7917776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.
    van Dongen RT; Crul BJ; Koopman-Kimenai PM; Vree TB
    Br J Clin Pharmacol; 1994 Sep; 38(3):271-3. PubMed ID: 7826830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney.
    Van Crugten JT; Sallustio BC; Nation RL; Somogyi AA
    Drug Metab Dispos; 1991; 19(6):1087-92. PubMed ID: 1687015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphine metabolism in children.
    Choonara IA; McKay P; Hain R; Rane A
    Br J Clin Pharmacol; 1989 Nov; 28(5):599-604. PubMed ID: 2590614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A highly sensitive assay for the simultaneous determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma by high-performance liquid chromatography with electrochemical and fluorescence detection.
    Rotshteyn Y; Weingarten B
    Ther Drug Monit; 1996 Apr; 18(2):179-88. PubMed ID: 8721282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
    Murthy BR; Pollack GM; Brouwer KL
    J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid.
    Wang Y; Goralski KB; Roberts DJ; Landry K; Issa ME; Sleno L; Julien LC; Wood J; Hall RI
    Can J Anaesth; 2017 Oct; 64(10):1009-1022. PubMed ID: 28710563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of two novel rectal controlled-release morphine formulations.
    Babul N; Darke AC; Anslow JA; Krishnamurthy TN
    J Pain Symptom Manage; 1992 Oct; 7(7):400-5. PubMed ID: 1484193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine.
    Heiskanen T; Backman JT; Neuvonen M; Kontinen VK; Neuvonen PJ; Kalso E
    Acta Anaesthesiol Scand; 2008 Nov; 52(10):1319-26. PubMed ID: 19025521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.